Volumetric and MGMT parameters in glioblastoma patients: survival analysis.
about
Delineation of radiation therapy target volumes for patients with postoperative glioblastoma: a reviewSomatic mutations associated with MRI-derived volumetric features in glioblastomaThe prognostic value of tumor necrosis in patients undergoing stereotactic radiosurgery of brain metastases.Predicting in vivo glioma growth with the reaction diffusion equation constrained by quantitative magnetic resonance imaging data.Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme.Chemoirradiation for glioblastoma multiforme: the national cancer institute experience.Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution.Plasma IGFBP-2 levels after postoperative combined radiotherapy and chemotherapy predict prognosis in elderly glioblastoma patients.Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survivalFully automatic GBM segmentation in the TCGA-GBM dataset: Prognosis and correlation with VASARI featuresA population-based study of high-grade gliomas and mutated isocitrate dehydrogenase 1.Clinical Evaluation of a Fully-automatic Segmentation Method for Longitudinal Brain Tumor Volumetry.Pre- and post-contrast three-dimensional double inversion-recovery MRI in human glioblastoma.Large-volume low apparent diffusion coefficient lesions predict poor survival in bevacizumab-treated glioblastoma patients.Volumetric quantification of glioblastoma: experiences with different measurement techniques and impact on survival.Algorithmic three-dimensional analysis of tumor shape in MRI improves prognosis of survival in glioblastoma: a multi-institutional study.New prognostic factor telomerase reverse transcriptase promotor mutation presents without MR imaging biomarkers in primary glioblastoma.Effect of 10 different polymorphisms on preoperative volumetric characteristics of glioblastoma multiforme.Ependymal enhancement on magnetic resonance imaging for the identification of high-grade gliomas.Recurrent glioblastoma: volumetric assessment and stratification of patient survival with early posttreatment magnetic resonance imaging in patients treated with bevacizumab.Semiautomated volumetric measurement on postcontrast MR imaging for analysis of recurrent and residual disease in glioblastoma multiforme.Evidence and Context of Use for Contrast Enhancement as a Surrogate of Disease Burden and Treatment Response in Malignant Glioma.Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma.Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation.Magnetic Resonance Spectroscopy, Positron Emission Tomography and Radiogenomics-Relevance to Glioma.Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics.Identifying the survival subtypes of glioblastoma by quantitative volumetric analysis of MRI.Prognostic paradox: brain damage around the glioblastoma resection cavity.Glioblastoma Survival Outcomes at a Tertiary Hospital in Appalachia: Factors Impacting the Survival of Patients Following Implementation of the Stupp Protocol
P2860
Q26745588-DEB04A11-C08C-409B-AF66-234CE64E0994Q28607337-CD399C7C-FD87-4F2D-BCB3-71AA939550C2Q30452422-59285819-3ABE-4833-AA21-1557C3CEC0EBQ30964764-7820466B-7846-45A4-A563-72284C999036Q34587527-983ECC07-EDE1-48F3-B6BD-BF65E9A417CBQ34935862-554DCDE6-FBFF-45AA-818F-B3932EEAFE7DQ34978253-D710247C-39EE-4DFD-81F0-D7465013B6CBQ35137451-9E0A1BC1-3057-46E9-9530-9A1486483337Q35707516-E4ECC015-AA35-4A74-9F11-CDD230B76444Q35843978-8BA74971-AA74-42B9-9ABC-B24A718FDA01Q36449844-E7189C92-7118-4E87-9B88-263B94DC8B51Q36713514-23ED815F-5560-4A19-9454-3913FF5FCF82Q36740494-7F2C88AE-D897-4DF6-8129-DE949743ABC9Q36785131-77914746-80F7-4E37-BB6B-D768779244C5Q38654095-37F75B2C-E07D-4315-A6D2-7C60BA170737Q39028007-B81EE4DF-8A4F-4BCD-A946-1372D2CFAF13Q40046161-A4BAEABA-9295-4AF2-B461-EE29629EBBD9Q40279363-4854C205-F506-402B-B049-FF07D7DCCE5FQ42276222-CA3128B1-2C46-4A09-A253-44692FAAFDF0Q43443828-BC9A3FAB-50EF-4CF0-A625-C9C3B5A6B939Q45124040-AE45DE9F-2CD7-4AED-AA5D-71B1DDB3E0F6Q47436703-05ABBC89-0E39-4CDC-9AFE-A94EDDDF2AFDQ48906044-46AE8A84-BA76-4145-9AAB-E8272B710503Q48930260-4235166E-1271-4292-9849-24C35CDD679BQ49829513-AE76FBF3-CD0F-4F3C-A42F-F72CA9E5D297Q55012452-031C8510-F1F5-43E8-B280-A6E48B478E4AQ55460927-59A2753D-02AD-4A4D-B19D-AF81E2A8CA03Q55461111-0F59EE19-0F59-426F-A6C9-FD0318ED94E3Q57179123-02F0CCB5-5EC2-4076-809F-CE7E9891A743
P2860
Volumetric and MGMT parameters in glioblastoma patients: survival analysis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Volumetric and MGMT parameters in glioblastoma patients: survival analysis.
@ast
Volumetric and MGMT parameters in glioblastoma patients: survival analysis.
@en
type
label
Volumetric and MGMT parameters in glioblastoma patients: survival analysis.
@ast
Volumetric and MGMT parameters in glioblastoma patients: survival analysis.
@en
prefLabel
Volumetric and MGMT parameters in glioblastoma patients: survival analysis.
@ast
Volumetric and MGMT parameters in glioblastoma patients: survival analysis.
@en
P2093
P2860
P356
P1433
P1476
Volumetric and MGMT parameters in glioblastoma patients: survival analysis.
@en
P2093
Anastasia G Eleftheraki
Athanasios Chatzisotiriou
Despina Misailidou
Despina Televantou
Georgios Iliadis
Panagiotis Selviaridis
Sofia Lambaki
Vassiliki Kotoula
P2860
P2888
P356
10.1186/1471-2407-12-3
P407
P577
2012-01-03T00:00:00Z
P5875
P6179
1013235261